Nantes University Hospital
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1503-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.chu-nantes.fr
Validation Study of a New Cytokine-based Dynamic Stratification Based on FLt3 Ligand Plasma Concentration Kinetic Profile and IL-6 Concentration During Induction of Acute Myeloid Leukemia
Recruiting
- Conditions
- Acute Myeloid Leukemia
- First Posted Date
- 2020-11-24
- Last Posted Date
- 2021-08-26
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 201
- Registration Number
- NCT04641910
- Locations
- 🇫🇷
Strasbourg University Hospital, Strasbourg, Bas-Rhin, France
🇫🇷Paoli-Calmette Institute, Marseille, Bouches-du-Rhône, France
🇫🇷Besançon University Hospital, Besançon, Doubs, France
REmimazolam Infusion in the Context of Hypnotic Shortage in the Critical Care Unit During the Pandemic of COVID-19: REHSCU Study
Phase 2
Completed
- Conditions
- Acute Respiratory FailureStrokeSepsisShockCOVID-19Trauma
- Interventions
- First Posted Date
- 2020-11-02
- Last Posted Date
- 2021-11-04
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT04611425
- Locations
- 🇫🇷
CHU de Nantes, Nantes, France
Study on the Prevalence of Hepatitis C In a psychiatRic Population
Not Applicable
Completed
- Conditions
- Hepatitis C
- Interventions
- Diagnostic Test: Evaluation of the prevalence of HCV, HBV and HIV viral infections
- First Posted Date
- 2020-10-23
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 796
- Registration Number
- NCT04600479
- Locations
- 🇫🇷
CHS de Blain, Blain, France
🇫🇷CH Georges Daumézon, Bouguenais, France
🇫🇷CHU Nantes, Nantes, France
Autobiographical Memory
Completed
- Conditions
- Autobiographical MemoryAlzheimer's DiseaseEye MovementMemory
- First Posted Date
- 2020-10-12
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 54
- Registration Number
- NCT04584138
- Locations
- 🇫🇷
CHU de Nantes, Nantes, France
Validation Study of the Feasibility of an Integrated Diagnostic System of Anatomo-pathological Lesions - Including Rejections - Appearing in Renal Grafts in the First Year of Transplant for Applicability in Routine Clinical Practice : KTD Innov-2 Study
- Conditions
- Kidney Transplant
- First Posted Date
- 2020-10-09
- Last Posted Date
- 2021-06-08
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT04581278
- Locations
- 🇫🇷
Nantes University Hospital, Nantes, Loire-Atlantique, France
Unruptured Cerebral Aneurysm: Prediction of Evolution
Recruiting
- Conditions
- Unruptured Intracranial Aneurysm
- First Posted Date
- 2020-10-08
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT04578808
- Locations
- 🇫🇷
Limoges University Hospital, Limoges, Haute-Vienne, France
🇫🇷Nancy University Hospital, Nancy, Meurthe-et-Moselle, France
🇫🇷Clairval's Hospital, Marseille, Bouches-du-Rhône, France
Validation of a Biomathematical Model to Help Identify the Parameters of Flexible Insulin Therapy
Not Applicable
Completed
- Conditions
- Type 1 Diabetes
- Interventions
- Other: Bio-mathematical modelOther: Without bio-mathematical model
- First Posted Date
- 2020-10-01
- Last Posted Date
- 2022-10-21
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 37
- Registration Number
- NCT04572009
- Locations
- 🇫🇷
CHU de Nantes, Nantes, France
Predictive Signature of Benralizumab Response
Phase 4
Recruiting
- Conditions
- Asthma; EosinophilicSevere Asthma
- Interventions
- First Posted Date
- 2020-09-25
- Last Posted Date
- 2024-04-26
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 220
- Registration Number
- NCT04565483
- Locations
- 🇫🇷
CHRU Brest, Brest, France
🇫🇷CHU Lille, Lille, France
🇫🇷CHU Rouen, Rouen, France
Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma
- First Posted Date
- 2020-09-23
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 45
- Registration Number
- NCT04561492
- Locations
- 🇫🇷
CHU Bordeaux, Bordeaux, France
🇫🇷CHU Lille, Lille, France
🇫🇷HCL, Lyon, France
Monocentric Phase 1 Study With Escalation of Doses of Tocilizumab in Combination With Chemotherapy (Idarubicin and Cytarabine) in Patients With Acute Myeloblastic Leukemia (AML)
Phase 1
Completed
- Conditions
- Acute Myeloid Leukemia (AML)
- First Posted Date
- 2020-09-14
- Last Posted Date
- 2023-04-28
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT04547062
- Locations
- 🇫🇷
CHU of Nantes, Nantes, France
© Copyright 2025. All Rights Reserved by MedPath